To determine the effects of lipid lowering by TLC on insulin sensitivity and secretory status of non-obese normoglycemic hyperlipidemic subjects. Methods: An intervention study was undertaken on 16 non-obese normoglycemic hyperlipidemic subjects. They underwent 6 months of a TLC regimen. Their insulin sensitivity and lipid status were assessed at baseline and after six months. A control group containing 16 age, sex and body mass index (BMI) matched normolipidemic subjects was also enrolled to compare the change in lipid levels and insulin sensitivity in the hyperlipidemic subjects. Results: The intervention showed significant reductions in insulin resistance (HOMA-IR reduced from 3.8 to 1.4, p 0.001) and improvement of insulin sensitivity (HOMA%S increased from 50.1% to 121.2%, p 0.004) in hyperlipidemic subjects with associated reductions in lipid levels. Conclusion: Lipid lowering in non-obese hyperlipidemic subjects may be associated with improvement of insulin sensitivity.
Introduction
Insulin resistance is related to the risk of developing the metabolic syndrome and cardiovascular diseases. Originally it was discussed in connection with the pathogenesis of type 2 diabetes, but in his Banting lecture, Reaven 1) connected it to many metabolic disorders such as glucose intolerance, dyslipidemia, hyperuricemia and hypertension. Subsequent research has now firmly established this concept [1] [2] [3] [4] , and the metabolic syndrome has become a major issue in clinical practice. It is still debated whether the metabolic syndrome is a fortuitous cluster of different metabolic abnormalities, or if insulin resistance is the underlying cause behind all abnormalities of the syndrome. Insulin resistance has also been reported in subjects with different dyslipidemia without the presence of obesity or other metabolic disorder. Different treatment regimens are also being proposed for dyslipidemia and insulin resistance. It is well-known that changes in dietary habits and exercise have beneficial effects on insulin sensitivity 5) ; however there are still problems of patient compliance in long-term lifestyle changes regimens. We were interested to study the insulin sensitivity of a population free from all possible confounders influencing insulin sensitivity, but having only an abnormal lipid pattern. From previous studies, we have seen hyperlipidemic subjects who have lower insulin sensitivity, even when they were free from obesity, diabetes, hypertension and diabetic family history in comparison to normolipdemic subjects of the same age and BMI (Al-Mahmood et al., unpublished data). From that study population we took a number of hyperlipidemic subjects with their matched controls and studied the effects of lifestyle changes (diet and exercise) on blood lipids and insulin sensitivity. Our aim was to find out the effectiveness of lipid-lowering customized lifestyle change regimens in improving insulin sensitivity. Additionally our aim was to propose a patientfriendly lifestyle change regimen which patients can comply with easily.
Methodology

Study Design and Subjects
Research volunteers were recruited from a previous cross-sectional study population who were staff of different schools and public offices in Kota Bharu, the capital city of the state of Kelantan in northeastern peninsular West Malaysia. For the cross-sectional study we circulated an open notice to all staff at each location to invite them to be involved in our initial screening program. Out of a total of 890 staff from different offices, 561 subjects participated in the screening program for the cross-sectional study (participation rate 63%). Subsequently 315 participants were excluded because they did not meet the selection criteria of the study. Finally, 246 subjects fulfilled the selection criteria and were recruited. Among this study population 118 were hyperlipidemic and 128 were normolipidemic according to the NCEP-ATP criteria 6) . All the study subjects were Malaysian Malay by ethnicity.
Selection criteria for recruitment were: 1) age between 30 to 60 years, 2) non-obese with BMI 25 kg/m 2 and waist circumference in males 102 cm and in females 88 cm 6) , 3) non-diabetic (confirmed by OGTT) and non-hypertensive (SBP 140 mmHg, DBP 90 mmHg without treatment), 4) without a family history of type 2 diabetes, and 5) non-smoker. Subjects suffering from chronic illnesses, ketosis, chronic liver or renal disease, and pregnant women were excluded from the study. Subjects taking anti-hypertensive drugs, steroids or hormonal products were also excluded 1) . Though recently International Diabetes Federation (IDF) proposed ethnic specific cut off points to define abdominal obesity, but we prepared our study design before that and we used NCEP ATP criteria. We were also interested to compare our study results with previous studies using NCEP ATP criteria.
From the hyperlipidemic subjects of the crosssectional study, 28 subjects were randomly chosen for the intervention program. Lifestyle intervention was performed on them for three consecutive months. Their anthropometric data, fasting blood glucose, insulin and lipid levels were measured at baseline. After three months of intervention, this 28 subject were divided into two groups, i.e., therapeutic lifestyle changes (TLC)-responding intervention group (n 16) and TLC-non-responding intervention group (n 12). For the following three months, both groups continued the TLC program, but the TLC-non-responding group was given simvastatin 20 mg daily. Following this intervention, their blood glucose, insulin and lipid levels were re-measured. To compare their change in insulin sensitivity a number of 28 (16 for TLC responding group and 12 for TLC non-responding group) age, sex and BMI-matched normolipidemic subjects were taken from the normolipidemic group as controls for the intervention subjects. They did not undergo any intervention program; only their anthropometric parameters, blood glucose, insulin and lipid levels were measured after six months. In this article we report the results of the 16 subjects who responded to TLC.
The subjects in intervention group were given detailed advice about how to achieve the goals of the intervention by the dietitian of the Hospital Universiti Sains Malaysia (HUSM). During first visit with the dietitian, dietary data was collected from the subjects using 24-hour diet recall and food frequency method. Based on each subject's body-weight, height, activity, biochemical and medical data, a modified diet was customized according to the recommendation of the NCEP-ATP 6) and each patient was advised to comply.
Additionally, these subjects also received individual guidance on increasing their level of physical activity (walking 30 minutes for 5 days in a week at a moderate intensity) from an exercise specialist of the Sports Science Unit. The subjects had a 2 km walking pretest 7) following a demonstration, and the 2 km walking test was conducted every month during the intervention period to ensure they were carrying on their regular physical activity.
Subjects were asked to maintain a food and activity diary which recorded all details concerning their daily food intake and activities. During the whole period of intervention one of the authors communicated frequently (at least twice in a month) with the subjects so that they complied with the prescribed exercises and filled in the food diary. The same author checked and signed their food diaries at least once every two weeks.
The study was approved by the Research and Ethical Committee, School of Medical Sciences, Universiti Sains Malaysia (USM). Written informed consent was taken from every participant of the study. The study method adhered to the existing Malaysian guidelines for International Committee on Harmonization of Good Clinical Practice (ICH-GCP) 8) .
Blood Collection and Biochemical Analysis
Blood specimens for insulin was collected in 5 mL plain Vacutainer ® tubes, for lipid profile in 5 mL Vac-utainer ® tubes with SST ® Gel and clot activator and for glucose in 2 mL fluoride oxalate tubes (NaF oxalate 2 ® ). All tubes used for blood collection were supplied by Becton Dickinson Vacutainer Systems 15336 (FD), Farklin Lakes, New Jersey, USA 074171885. Plasma glucose and lipid levels were performed on the same day of blood collection. Serum for insulin was frozen immediately at 80 and was assayed within three months of specimen collection.
All blood analyses were performed in ISO-9001 certified laboratories using commercial kits and automated fully enzymatic colorimetric methods on the Cobas Integra 400 ® automated chemistry analyzer (ROCHE ® , Switzerland). Plasma glucose was estimated by the glucose oxidase (GOD-PAD) method (inter-assay coefficient of variation (CV) 2.45%). Serum total cholesterol was estimated by the cholesterol oxidase-peroxidase (CHOD-PAP) method (inter-assay CV 1.27%). HDL cholesterol was estimated following chemical precipitation with phosphotungstic reagent and subsequent CHOD-PAP method (inter-assay CV 1.26%). Triglyceride was estimated by the glycerol oxidase-peroxidase (GPO-PAP) method (inter-assay CV 1.38%). The LDL cholesterol level in serum was calculated by using the Friedewald formula 9) . Very low density lipoprotein (VLDL) cholesterol was calculated by dividing the triglyceride level by 2.2. Serum insulin (inter-assay CV 1.39%) was measured by chemiluminescence method on the IMMULITE ® analyzer (Diagnostics Products Corporation EURO/DPC, United Kingdom).
Homeostasis Model Assessment (HOMA)
Homeostasis model assessment (HOMA) software was used to calculate insulin sensitivity (HOMA%S) and insulin secretory capacity (HOMA%B) of the subjects. Fasting insulin levels in (pmol/L) and fasting plasma glucose in (mmol/L) were keyed into the computer using the HOMA software to calculate HOMA%S and HOMA%B [10] [11] [12] [13] . HOMA for insulin resistance (HOMA-IR) was also calculated manually using the following formula in order to compare the results of this study with those of previous studies 10) : HOMA-IR (fasting insulin in IU/mL fasting glucose in mmol/L) 22.5
Statistical Analyses
Statistical analyses were done using the Statistical Package for Social Sciences (SPSS) for Windows version 11.0 14) . Insulin sensitivity of the different groups was expressed as mean (SD), or median and interquartile range (IQR) according to data distribution. Differences of insulin sensitivity between two groups before and after intervention were compared using repeated measures ANOVA test. Table 1 shows the demographic characteristics of subjects who participated in the intervention programs with their corresponding controls. Subjects of both groups were age-sex-BMI-matched.
Results
Characteristics of Study Subjects
Clinical and Anthropometric Background
Anthropometric measures in the intervention group and their matched controls, before and after intervention, are shown in Table 2 . Significant changes were seen in waist circumference (p 0.001) in the TLC-responding hyperlipidemic subjects following six months intervention, their BMI also reduced though the change was not statistically significant. The control subjects without any intervention showed no significant change in their BMI, waist circumference and WHR during the same period.
Improvement of Lipid Profile
Intervention caused significant reduction of total cholesterol and LDL-C in the hyperlipidemic subjects. (Table 3 ). In the TLC-responding group the intervention programs reduced median total cholesterol from 6.6 mmol/L to 5.8 mmol/L (p 0.001), and mean LDL-C from 4.5 mmol/L to 3.7 mmol/L (p 0.004). There was also marginal improvement in mean TG and HDL-C levels ( Table 3) .
Fasting Glycemia and Insulin Sensitivity Status
In the hyperlipidemic group, the intervention programs and associated improvement in lipid levels were accompanied by improvement in insulin sensitivity. Fasting insulin levels reduced from 115.9 pmol/L before intervention to 47.1 pmol/L after six months intervention by lifestyle changes (p 0.001) ( Table 4) . The median insulin sensitivity (HOMA%S) rose from 50.1% before intervention to 121.2% after interven- tion (p 0.004). There was reduction in the median insulin secretory capacity (HOMA%B) from 233.6% before intervention to 139.4% after intervention (p 0.002). The median insulin resistance (HOMA-IR) reduced from 3.8 to 1.4 (p 0.001) ( Table 4) .
Discussion
The results of the present intervention study showed significant effects of lifestyle changes on insulin sensitivity in non-obese normoglycemic hyperlipidemic subjects. The intervention program and associated improvements in lipid levels were accompanied by improvement in insulin sensitivity and secretion. There was a significant lowering of mean fasting insulin levels, mean insulin resistance (HOMA-IR) and improvement of mean insulin sensitivity (HOMA%S). There was also a significant effect of lifestyle change intervention in lowering insulin secretory capacity (HOMA%B). So the novel finding of this research is that lowering of total cholesterol and LDL-C are associated with improvement of insulin sensitivity.
There are other reports which have obtained similar results to this study. Kishimoto et al. (2002) studied the effects of exercise on insulin sensitivity, insulin secretion and lipid metabolism in 39 non-obese type 2 diabetic Japanese patients 15) . They found that 7 days low intensity exercise improved HOMA-IR from 2.4 to 1.6 with a reduction of total cholesterol from 202 mg/dL to 190mg/ dL and TG from 149 mg/dL to 113 mg/dL. They concluded that physical exercise in nonobese Japanese diabetic patients was a useful means for lowering serum lipids and improving insulin sensitivity 15) . Similarly a study by Tan 16) involving diabetic Malay subjects (n 11, mean BMI 26.0 kg/m 2 ) also found that HOMA-IR improved from 4.3 to 3.8 after 12 weeks of exercise 16) . Alam et al. (2004) also obtained similar findings when they prescribed 20-40 minutes exercise, four days per week for 6 months to 9 overweight diabetic subjects. The intervention caused a reduction of HOMA-IR from 8.2 to 5.2 17) . Investigating the effect of brisk walking on 18 sedentary 14 n is the number of study subjects; BMI is body mass index; WHR is waist-to-hip ratio.
Comparisons within the groups before and after intervention were performed by paired Student's t-test. Table 3 . Lipid levels of TLC-responding subjects and controls before and after intervention adults, Duncan et al. (2000) found that even modest amounts of exercise caused a 73% improvement in insulin sensitivity 18) . Effects of exercise and dietary changes on eight subjects with visceral adiposity who performed 7 days intensive in-hospital intervention, significantly lowered fasting insulin levels and also improved capacity for insulin release 19) .
In the last few years there has been a decisive shift in the focus of lipid trials from populations with high LDL-C to populations with a more modest LDL-C. Our intervention study justified this by showing its effectiveness in lowering insulin resistance in otherwise healthy moderately hyperlipidemic subjects. These days, lifestyles are moving from manual to sedentary, diets tend to include more refined and less fiber containing foods, and obesity is increasing. These changes are associated with rapidly increasing rates of diabetes and cardiovascular disease. Our results suggest that dietary and exercise interventions are effective methods of preventive intervention.
Lifestyle changes results in reduction of atherogenic lipids, and are also associated with a reduction in BMI and waist circumference. In our study, a repeated measure ANOVA test was done to assess the changes in insulin sensitivity adjusted for change in BMI and waist circumference, and this also showed significant change ( Table 4) . This indicates that changes in blood lipids may be linked with changes in insulin sensitivity.
From this study, it was also established that lifestyle changes involving customized dietary manipulation and a moderate form of exercise (walking 30 minutes for 5 days in a week) had good compliance, and a positive influence in improving mild lipid abnormalities and insulin sensitivity. This also has practical significance because often heavy exercise and major change in diet pattern are associated with poor compliance by patients. Out of 28 hyperlipidemic subjects participating in the TLC programme all were compliant with the program though blood lipids of 12 subjects did not responded up to the level so they needed medicine with TLC.
A limitation of our study may be that all participants were well educated, and it may be that lifestyle intervention is less well received by subjects with lower levels of education. Another limitation is that to define abdominal obesity we used NCEP ATP criteria, because we prepared this study design in early 2003 and finished collection of sample within 2004, though recently IDF proposed ethnic specific cut off points to define abdominal obesity. This was not a randomized control study; participation was voluntary so chances of selection bias cannot be excluded, moreover number of participants was small. Nevertheless, our results show that when hyperlipidemic subjects undertake modest lifestyle changes, this can be associated with enormous metabolic benefits.
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